Intervention Protocol

You have free access to this content

Neuromuscular electrostimulation for chronic obstructive pulmonary disease

  1. Kylie Hill1,*,
  2. Sunita Mathur2,
  3. Marc Roig3,
  4. Tania Janaudis-Ferreira2,4,5,
  5. Priscila Robles2,
  6. Thomas E Dolmage6,
  7. Roger Goldstein5

Editorial Group: Cochrane Airways Group

Published Online: 27 NOV 2013

DOI: 10.1002/14651858.CD010821


How to Cite

Hill K, Mathur S, Roig M, Janaudis-Ferreira T, Robles P, Dolmage TE, Goldstein R. Neuromuscular electrostimulation for chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010821. DOI: 10.1002/14651858.CD010821.

Author Information

  1. 1

    Curtin University, School of Physiotherapy and Exercise Science, Faculty of Health Science, Perth, Western Australia, Australia

  2. 2

    University of Toronto, Toronto, Ontario, Canada

  3. 3

    McGill University, School of Physical & Occupational Therapy, Faculty of Medicine, Montreal, Quebec, Canada

  4. 4

    Sunnybrook Health Sciences Centre, St John's Rehab Program, Sunnybrook Research Institute, Toronto, Canada

  5. 5

    West Park Healthcare Centre, University of Toronto, Division of Respiratory Medicine, Toronto, Canada

  6. 6

    West Park Healthcare Centre, Respiratory Diagnostic & Evaluation Services, Toronto, Canada

*Kylie Hill, School of Physiotherapy and Exercise Science, Faculty of Health Science, Curtin University, GPO Box U1987, Perth, Western Australia, WA 6845, Australia. K.Hill@curtin.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 27 NOV 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effects of NMES, applied in isolation or as an adjunct to whole-body exercise training, on muscle function (i.e. force-generating capacity and endurance), muscle size, exercise capacity, functional performance, symptoms, HRQoL and adverse events in people with COPD.